Abstract
The development of new immune treatment in oncology and particularly for lung cancer may induce new complications, particularly activation or reactivation of auto-immune diseases. In this context, a systematic review on the auto-immune paraneoplastic syndromes that can complicate lung cancer appears useful. This article is the third of a series of five and deals mainly with neurological paraneoplastic syndromes involving the central nervous system.
Copyright © 2017 Elsevier B.V. All rights reserved.
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
England
-
Female
-
Humans
-
Immunotherapy / adverse effects*
-
Lung Neoplasms / complications*
-
Lung Neoplasms / drug therapy
-
Male
-
Middle Aged
-
Nervous System Autoimmune Disease, Experimental / chemically induced*
-
Paraneoplastic Syndromes, Nervous System / chemically induced
-
Paraneoplastic Syndromes, Nervous System / immunology*
-
Paraneoplastic Syndromes, Nervous System / pathology
-
Prospective Studies
-
Small Cell Lung Carcinoma / complications*
-
Small Cell Lung Carcinoma / drug therapy